Vertex Pharmaceuticals Inc. Stock
A loss of -2.960% shows a downward development for Vertex Pharmaceuticals Inc..
Our community is currently high on Vertex Pharmaceuticals Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of €250.00 there is a hugely positive potential of 54.722% for Vertex Pharmaceuticals Inc. compared to the current price of €161.58.
So far the community has only identified positive things for Vertex Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Vertex Pharmaceuticals Inc. in the next few years
Pros
3
Could be very worthwhile Investment >20% year
1
Small cyclical dependencies
1
Well known brand
Cons
0
-
Performance of Vertex Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -2.960% | -0.284% | 1.802% | -11.181% | -15.536% | 9.933% | 97.833% |
| Exact Sciences | -4.350% | 1.289% | -7.660% | -22.358% | -29.661% | 30.463% | 415.015% |
| Regeneron Pharmaceuticals Inc. | -1.620% | -1.764% | 11.266% | 34.430% | 44.155% | 82.078% | 51.804% |
| Incyte Corp. | 2.630% | 3.885% | 3.451% | -12.885% | -15.273% | -0.486% | -41.552% |
Comments
Other discussions about Vertex Pharmaceuticals Inc. Stock
Trading Vertex Pharmaceuticals Inc.
Trading Vertex Pharmaceuticals Inc.
